Whole-Transcriptome Profiling of Murine GL261 Glioma Reveals Signatures Consistent with Distinct Immune Reprogramming Induced by Oncolytic Virotherapy with VV-GMCSF-Lact and Anti-PD-1 Therapy
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188078 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Anna S Chesnokova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Lavrentyev Avenue 8, Novosibirsk 630090, Russia. Hauptthemen laut MEDLINE: Glioma, Oncolytic Virotherapy, Programmed Cell Death 1 Receptor, Granulocyte-Macrophage Colony-Stimulating Factor. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Russian state funded project for ICBFM SB RAS, Russian state-funded.
Abstract (Originalsprache)
Both oncolytic virotherapy and immune checkpoint blockade are being actively explored as immunotherapy treatments for glioblastoma, one of the most lethal malignancies. Nevertheless, the antitumor molecular mechanisms of these therapies remain poorly understood, particularly whether they induce overlapping or distinct transcriptional programs. No comprehensive transcriptome-wide characterization and direct comparison of the responses induced by VV-GMCSF-Lact and anti-PD-1 therapy in glioma have been reported. To address this question, we performed whole-transcriptome profiling of GL261 tumors from immunocompetent C57BL/6 mice treated with VV-GMCSF-Lact, anti-PD-1 antibodies, or their combination. We analyzed therapy-associated changes in gene expression, signaling pathways, and tumor composition. Our findings indicate that anti-PD-1 and combination treatment led to distinctive activation of interferon-gamma response, JAK/STAT signaling, and TNF-alpha/NF-kB pathways. In contrast, VV-GMCSF-Lact preferentially activated T, B, and natural killer T cell-associated programs and reduced the relative abundance of malignant cells. Notably, combination therapy was associated with unique molecular patterns, including induction of monocyte and granulocyte chemotaxis-associated genes, downregulation of PP2A-regulated signaling, and suppression of Rap1-related pathways. This suggests that VV-GMCSF-Lact and anti-PD-1 therapy induce transcriptionally distinct, yet complementary, immune reprogramming and support further evaluation of their combination for glioma immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Lavrentyev Avenue 8, Novosibirsk 630090, Russia.
- Research Center for Genetics and Life Sciences, Sirius University of Science and Technology, Krasnodar Region, Sirius (Federal Territory of Sirius), Sochi 354340, Russia.
- State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor, Koltsovo 630559, Russia.
- Oncostar LLC, Inzhenernaya Street 23, Novosibirsk 630090, Russia.
ORCID-Profile: Anna S Chesnokova, Alisa B Ageenko, Natalia S Vasileva, Arina A Byvakina, Anna A Nushtaeva, Anastasia A Leonteva, Galina V Kochneva, Elena V Kuligina, Dmitriy V Semenov
Förderung
- Russian Science Foundation
- Russian state funded project for ICBFM SB RAS
- Russian state-funded
Zitieren
APA
Chesnokova, A. S., Ageenko, A. B., Vasileva, N. S., Byvakina, A. A., Nushtaeva, A. A., Leonteva, A. A., Savinovskaya, Y. I., Kochneva, G. V., Richter, V. A., Kuligina, E. V., & Semenov, D. V. (2026). Whole-Transcriptome Profiling of Murine GL261 Glioma Reveals Signatures Consistent with Distinct Immune Reprogramming Induced by Oncolytic Virotherapy with VV-GMCSF-Lact and Anti-PD-1 Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188078
Vancouver
Chesnokova AS, Ageenko AB, Vasileva NS, Byvakina AA, Nushtaeva AA, Leonteva AA, et al. Whole-Transcriptome Profiling of Murine GL261 Glioma Reveals Signatures Consistent with Distinct Immune Reprogramming Induced by Oncolytic Virotherapy with VV-GMCSF-Lact and Anti-PD-1 Therapy. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188078
BibTeX
@article{Chesnokova2026,
author = {Chesnokova, Anna S and Ageenko, Alisa B and Vasileva, Natalia S and Byvakina, Arina A and Nushtaeva, Anna A and Leonteva, Anastasia A and Savinovskaya, Yulya I and Kochneva, Galina V and Richter, Vladimir A and Kuligina, Elena V and Semenov, Dmitriy V},
title = {Whole-Transcriptome Profiling of Murine GL261 Glioma Reveals Signatures Consistent with Distinct Immune Reprogramming Induced by Oncolytic Virotherapy with VV-GMCSF-Lact and Anti-PD-1 Therapy},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188078}
}
EUVIMED